STAT - Reporting from the frontiers of health and medicine

A STAT Investigation

Health Tech

First Opinion

By Yotam Dagan

Health First-of-its-kind study pits psilocybin against a common antidepressant
First Opinion Looking back at 15 years of sharing viral genomes to forge ahead
Politics PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform
First Opinion Podcast Listen: Two addiction specialists debunk the myth of ‘excited delirium’ used in police encounters
Pharma Europe tries to lower drug prices with small doses of transparency

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

FDA is urged to move faster to list medicines withdrawn over safety concerns
Tango Therapeutics to go public in $353 million SPAC deal
A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements

Health Tech

Health

A STAT Investigation

A STAT Investigation

Biotech

In Memoriam

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Health Why would a Covid vaccine cause rare blood clots? Researchers have found clues
Health First-of-its-kind study pits psilocybin against a common antidepressant
Health U.S. urges pause on use of Johnson & Johnson Covid-19 vaccine after rare blood clotting cases
A STAT Investigation Cement Head’s last fight: He was denied parole six times — until he was about to become a Covid-19 statistic
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Exclusive Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine
First Opinion Federal law prohibits employers and others from requiring vaccination with a Covid-19 vaccine distributed under an EUA